| Financial Year |
March 31 2023 |
| Monetary Funds |
5,206,664,621.28 |
| Held-for-trading Financial Assets |
1,702,361,613.67 |
| Notes Receivable |
2,011,479,674.75 |
| Accounts Receivable |
2,023,717,597.84 |
| Advances to Suppliers |
442,661,450.02 |
| Other Receivables |
52,773,058.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,783,986,118.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
204,245,935.03 |
| Other Current Assets |
172,415,392.71 |
| Total Current Assets |
21,614,481,998.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
31,169,387.26 |
| Long-term Equity Investment |
58,603,024.96 |
| Investment Properties |
-- |
| Fixed Assetes |
490,651,273.20 |
| Under-construction Projects |
203,204,250.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
147,841,080.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,348,929.24 |
| Deferred Income Tax Assets |
170,351,786.25 |
| Other Non-Current Assets |
128,851,806.16 |
| Sub-Total of Non-Current Assets |
1,634,266,893.81 |
| Total Assets |
23,248,748,892.47 |
| Short-Term Loans |
302,210,227.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,054,759,698.39 |
| Accounts Payable |
4,564,489,004.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
109,183,393.36 |
| Taxes Payable |
57,246,559.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
134,945,961.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,159,837.96 |
| Other Current Liabilities |
432,799,080.34 |
| Sub-Total of Current Liabilities |
15,444,629,162.82 |
| Long-term Loans |
220,155,833.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
36,350,783.49 |
| Deferred Income Tax Liabilities |
943,474.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
276,601,898.15 |
| Total Liabilities |
15,721,231,060.97 |
| Paid-In Capital(Or Share Stock) |
348,233,546.00 |
| Capital Surplus |
3,658,858,573.17 |
| Surplus Reserve |
174,116,773.00 |
| LESS:Treasury Stock |
7,645,838.69 |
| Undistributed Profits |
3,353,809,978.53 |
| Minority Stockholder's Interest |
753,507.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,526,764,324.09 |
| Owner's Equity（Stockholder's Equity） |
7,527,517,831.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,248,748,892.47 |
